Joel Charrow

THREE YEAR VISUAL OUTCOMES AFTER CHEMOTHERAPY FOR NF1 OPTIC PATHWAY GLIOMAS IN CHILDREN

Laura J. Balcer, Michael Fisher, Nicole J. Ullrich, 2012 .

DYNAMIC CHANGES IN LONG-TERM VISUAL OUTCOME AFTER TREATMENT OF CHILDREN WITH NF1 OPTIC PATHWAY GLIOMAS

Laura J. Balcer, Michael Fisher, Nicole J. Ullrich, 2012 .

Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.

Uri Tabori, Joel Charrow, Eric Bouffet, 2012, Neuro-oncology.

Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.

Michael J Parker, Katrina Tatton-Brown, Christian Gilissen, 2015, American journal of human genetics.

Tandem mass spectrometry in newborn screening: American College of Medical Genetics/American Society of Human Genetics Test and Technology Transfer Committee Working Group

Joel Charrow, Piero Rinaldo, J. Charrow, 2000, Genetics in Medicine.